- Home
- FTHM vs RVPH Comparison
FTHM vs RVPH Comparison
Compare FTHM & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- RVPH
- Stock Information
- Founded
- FTHM 2010
- RVPH 2006
- Country
- FTHM United States
- RVPH United States
- Employees
- FTHM N/A
- RVPH N/A
- Industry
- FTHM Real Estate
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- RVPH Health Care
- Exchange
- FTHM Nasdaq
- RVPH Nasdaq
- Market Cap
- FTHM 33.6M
- RVPH 36.7M
- IPO Year
- FTHM 2020
- RVPH N/A
- Fundamental
- Price
- FTHM $1.06
- RVPH $0.70
- Analyst Decision
- FTHM Buy
- RVPH Strong Buy
- Analyst Count
- FTHM 1
- RVPH 5
- Target Price
- FTHM $2.50
- RVPH $9.00
- AVG Volume (30 Days)
- FTHM 61.8K
- RVPH 662.3K
- Earning Date
- FTHM 08-11-2025
- RVPH 08-13-2025
- Dividend Yield
- FTHM N/A
- RVPH N/A
- EPS Growth
- FTHM N/A
- RVPH N/A
- EPS
- FTHM N/A
- RVPH N/A
- Revenue
- FTHM $357,816,000.00
- RVPH N/A
- Revenue This Year
- FTHM $32.40
- RVPH N/A
- Revenue Next Year
- FTHM $18.04
- RVPH N/A
- P/E Ratio
- FTHM N/A
- RVPH N/A
- Revenue Growth
- FTHM 5.80
- RVPH N/A
- 52 Week Low
- FTHM $0.65
- RVPH $0.49
- 52 Week High
- FTHM $3.37
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- FTHM 46.00
- RVPH 39.46
- Support Level
- FTHM $1.03
- RVPH $0.67
- Resistance Level
- FTHM $1.36
- RVPH $0.90
- Average True Range (ATR)
- FTHM 0.10
- RVPH 0.06
- MACD
- FTHM -0.03
- RVPH -0.02
- Stochastic Oscillator
- FTHM 13.04
- RVPH 11.36
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.